Fillerina, page-8

Hi Pharma,

the concept of Mr Market is often used by detractors as a guide to the irrelevance of the companies strategies. I prefer to gauge the actions of the Company and how the market will ultimately assess the success of those actions.  The Notes to the 4C provide me with significant confidence that the increase in business costs will be clearly covered by the economies of scale and utilisation of existing marketing and distribution channels across the global distribution model ( EU must  be pending imo...is the CEO Overeas at the moment ???...see slide 22 of July market presentation.

Also from the Cellmid Market Presentation  "FY19 expected to be a breakout year".  The unusual clarity and forthright tone of this presentation is not one of hope rather insight and confidence.

Yes indeed Pharma as you pointed out the big money " Market" is already showing an interest.  Possibly FOMO not far away post the raising.